Global mapping of c-Myc binding sites and target gene networks in human B cells

Karen I Zeller1, XiaoDong Zhao, Charlie W H Lee

  • 1Department of Medicine and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Insights

This study identifies direct Myc targets in human B lymphoid tumors, revealing 668 regulated genes. These findings offer a framework for understanding how MYC drives tumorigenesis and controls cell growth.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • The protooncogene MYC (c-Myc) is crucial for cell growth, proliferation, and apoptosis.
  • MYC deregulation is implicated in tumorigenesis, but direct Myc-induced transcriptomes driving transformation remain unclear.

Purpose of the Study:

  • To perform a genome-wide characterization of direct Myc binding targets in a human B lymphoid tumor model.
  • To identify genes directly regulated by Myc and understand its role in transcriptional control.

Main Methods:

  • Utilized Chromatin Immunoprecipitation coupled with pair-end ditag sequencing analysis (ChIP-PET).
  • Integrated ChIP-PET data with gene expression profiles to identify direct Myc targets.

Main Results:

  • Myc potentially occupies over 4,000 genomic loci, primarily near proximal promoter regions and CpG islands.
  • Identified 668 direct Myc-regulated genes, including 48 transcription factors.
  • Myc acts as a central transcriptional hub controlling growth and proliferation.

Conclusions:

  • Provides the first global genomic view of Myc binding sites.
  • Offers insights into Myc-involved transcriptional circuitries and cis-regulatory modules.
  • Establishes a framework for understanding Myc-induced tumorigenesis mechanisms.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...